In this guide, well walk through head-to-head comparisons from clinical studies, unpack differences in tolerability, and explore real-world experiences
All three medications reduce triglycerides, but retatrutide produces the largest reductions, likely because of the glucagon-driven increase in fat oxidation
Promising therapeutics include semaglutide (Ozempic and Wegovy ), an agonist for glucagon-like peptide-1 (GLP-1) receptor, and tirzepatide (Mounjaro ), a dual agonist for GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors
Use extra caution if you have a history of pancreatitis, gallbladder disease, severe gastrointestinal disease, or diabetic retinopathy
ondansetron)
Step 3: Inject the medication Gently pinch a fold of skin at the cleaned site